RGEN

RGEN

USD

Repligen Corporation Common Stock

$146.930-2.130 (-1.429%)

实时价格

Healthcare
Medical Instruments & Supplies
美国

价格图表

Loading Chart...

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$149.060

最高价

$151.250

最低价

$146.000

成交量

0.61M

公司基本面

市值

8.3B

所属行业

Medical Instruments & Supplies

国家/地区

United States

交易统计

平均成交量

0.92M

交易所

NMS

货币

USD

52周价格范围

最低价 $102.97当前价 $146.930最高价 $182.52

相关新闻

GlobeNewswire

Repligen Corporation to Present at Upcoming November Conferences

WALTHAM, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be attending five upcoming

查看更多
Repligen Corporation to Present at Upcoming November Conferences
Analyst Upgrades

Canaccord Genuity Maintains Hold on Repligen, Raises Price Target to $165

Canaccord Genuity analyst Kyle Mikson maintains Repligen with a Hold and raises the price target from $150 to $165.

查看更多
Canaccord Genuity Maintains Hold on Repligen, Raises Price Target to $165
Analyst Upgrades

Barclays Maintains Overweight on Repligen, Raises Price Target to $175

Barclays analyst Luke Sergott maintains Repligen with a Overweight and raises the price target from $160 to $175.

查看更多
Barclays Maintains Overweight on Repligen, Raises Price Target to $175
GlobeNewswire

Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance

Revenue of $189 million, year-over-year increase of 22% as reported and 18% organic with double-digit reported growth across all franchisesOrders increased sequentially and greater than 20% year-over-yearIncreasing

查看更多
Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance
GlobeNewswire

Repligen to Report Third Quarter 2025 Financial Results

WALTHAM, Mass., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its third quarter 2025 financial results on Tuesday, October 28, 2025. The Company will

查看更多
Repligen to Report Third Quarter 2025 Financial Results